Evolva (EVE)

Business description

Evolva is a Swiss high-tech fermentation company. It has a proprietary yeast technology platform, which it uses to create and manufacture high-value speciality molecules for nutritional and consumer products.

Stock data

Market cap.CHF203.6m
Last closeCHF0.48
High / Low (52 weeks)CHF0.9 / CHF0.4
Stock market listingSW
Forecast net cash (CHFm)33.2
Forecast gearing ratio (%)N/A
TeamConsumer
SectorFood & Drink

Price performance

%1m3m12m
Actual(12.7)(15.8)(21.3)
Relative *(15.9)(20.5)(28.1)

* % Relative to local index

Other companies in sector Show

Company news

BRIEF-Evolva Holding teams up with FCI to expand nootkatone and valencene in ...

Thu, 16 Mar 2017 06:11:15 GMT

0.4586

Fri, 22 Nov 2013 11:19:43 GMT

Investors Peering into the Details on Evolva Holding SA (SWX:EVE)

Fri, 26 May 2017 22:30:00 GMT

Evolva Holding: On Track

Thu, 01 Sep 2016 13:30:00 GMT

Evolva to Acquire Allylix

Tue, 18 Nov 2014 06:01:29 GMT

Y/E Dec Revenue (CHFm) EBITDA (CHFm) PBT (CHFm) EPS (CHF) P/E (x) P/CF (x)
2015A 13.4 (30.3) (32.1) (8.0) N/A N/A
2016A 9.6 (34.0) (35.9) (7.8) N/A N/A
2017E 15.3 (23.5) (24.6) (6.0) N/A N/A
2018E 23.3 (20.4) (21.0) (5.0) N/A N/A

Last updated on 09/05/2017

Latest research

Agreement reached

Outlook | Food & Drink | 09/05/2017

Headroom improves

Update | Food & Drink | 16/03/2017

A cloudier picture

Update | Food & Drink | 16/01/2017

On track

Update | Food & Drink | 01/09/2016

Positive stevia newsflow

Update | Food & Drink | 07/06/2016

Stevia delayed

Update | Food & Drink | 06/04/2016

Tastes good

Outlook | Food & Drink | 15/01/2016

Getting sweeter

QuickView | Food & Drink | 19/11/2015

Rights issue supports stevia JV

Update | Food & Drink | 07/09/2015

Manufacturing a sweeter future

Update | Pharmaceutical & healthcare | 18/05/2015

Daily comment

Institutional Comment | Pharmaceutical & healthcare | 11/02/2015

Gaining dominance

Update | Pharmaceutical & healthcare | 11/02/2015

Investment summary

EverSweet is due to be launched in 2018 following the recent, much-awaited collaboration agreement with Cargill. Evolva is due to participate in the JV at the 30% level, and will also benefit from a new state-of-the-art bioprocessing facility for its other products. Our fair value is CHF0.81 per share and we believe the current share price offers a good entry point.

Last updated on 09/05/2017

Industry outlook

The manufacturers of nutritional and consumer health products are always interested in cheaper production methods, especially if the product is natural and has health benefits. Evolva is primarily targeting this market.

Last updated on 02/05/2017

Key management

Sir Tom McKillop, Chairman
Neil Goldsmith, CEO
Oliver Walker, CFO

Company address

Duggingerstrasse. 23
Reinach
CH-4153
Switzerland
+41 61 485 2000
View website